Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

rEV-131 studied in new trial for inflammation following cataract surgery

June 23, 2006

No Comments

ISTA licenses new investigational glaucoma products from Senju

June 22, 2006

No Comments

Series A financing to fund development of Danube's oral glaucoma therapy

June 19, 2006

No Comments

MabThera recommended for European approval for rheumatoid arthritis

June 7, 2006

No Comments

Initial increase in vision from baseline with monthly dosing of Lucentis

June 7, 2006

No Comments

New therapeutic agents for ocular disorders disclosed

June 6, 2006

No Comments

Macugen, new wet AMD treatment in U.K.

June 1, 2006

No Comments

ISTA begins pivotal studies for once-daily Xibrom

May 31, 2006

No Comments

Orally available calpain inhibitor provides in vivo neuroprotection against retinal ischemia

May 31, 2006

No Comments

Isotechnika licenses ISA-247 to Lux for ophthalmic indications

May 30, 2006

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

rEV-131 studied in new trial for inflammation following cataract surgery

ISTA licenses new investigational glaucoma products from Senju

Series A financing to fund development of Danube's oral glaucoma therapy

MabThera recommended for European approval for rheumatoid arthritis

Initial increase in vision from baseline with monthly dosing of Lucentis

New therapeutic agents for ocular disorders disclosed

Macugen, new wet AMD treatment in U.K.

ISTA begins pivotal studies for once-daily Xibrom

Orally available calpain inhibitor provides in vivo neuroprotection against retinal ischemia

Isotechnika licenses ISA-247 to Lux for ophthalmic indications

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Ocular RSS

Ocular
RSS